Grant: Engage Grants Program
University of Guelph
$25,000.00
Control of Paenibacillus larvae, the causative agent of American Foulbrood in honeybees
EF 2015-16
Résumé
Bees as pollinators play a critical role in efficient plant and crop pollination for global food production. Managed colonies of the honey bee, Apis mellifera, provide nearly 90% of the commercial pollination service in global agriculture making honeybees one of the most important livestock animals. Honeybees are vitally important to Canadian food production with an estimated value of $2 billion annually arising from their pollination services. These insects are facing a host of threats, from blood-sucking mites and harmful microbes, to pesticides and climate change. Thus, honeybee health is of critical global relevance and research leading to the understanding and treatment of bee diseases such as American Foulbrood (AFB) are considered paramount. AFB is the most common and destructive of the bee brood diseases and is caused by Paenibacillus larvae, which is a gram-positive, spore-forming bacterium that has become a honeybee pathogen. P. larvae is controlled through antibiotic therapy to non-resistant strains of the pathogen, although there is a thrust to develop alternative treatment strategies including natural antimicrobial compounds such as oils from various plants. Importantly, resistance is rising to oxytetracycline hydrochloride (Terramycin) and new strategies such as the novel antivirulence approach are urgently needed for prevention and control of AFB. Dr. Merrill at the University of Guelph will work with Syngenta Canada to develop effective compounds for treating AFB in honeybees, with a special focus on natural products that serve as therapeutics against the honeybee pathogen. Dr. Merrill's team has developed a rapid and powerful strategy for the discovery and characterization of novel therapeutics against bacterial toxins and they are using this approach to identify new antibacterial compounds
with radically different mechanisms of action which represents an innovative therapeutic concept. To date, the Merrill team has identified a suite of potent inhibitors against the causative agent of AFB, Paenibacillus larvae and its associated virulence factors (toxins) for application in combating this honeybee brood disease. These inhibitors work against the toxins both in vitro and in cell culture. Field studies are needed to test their efficacy
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
491651-2015
Name nom
Merrill, Rod
Department département
Molecular and Cellular Biology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1209
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Agriculture
Area of application fr
Agriculture
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Partie
1
Nb partie
1
Application title
Control of Paenibacillus larvae, the causative agent of American Foulbrood in honeybees
Keyword
NSERC
Application summary
Bees as pollinators play a critical role in efficient plant and crop pollination for global food production. Managed colonies of the honey bee, Apis mellifera, provide nearly 90% of the commercial pollination service in global agriculture making honeybees one of the most important livestock animals. Honeybees are vitally important to Canadian food production with an estimated value of $2 billion annually arising from their pollination services. These insects are facing a host of threats, from blood-sucking mites and harmful microbes, to pesticides and climate change. Thus, honeybee health is of critical global relevance and research leading to the understanding and treatment of bee diseases such as American Foulbrood (AFB) are considered paramount. AFB is the most common and destructive of the bee brood diseases and is caused by Paenibacillus larvae, which is a gram-positive, spore-forming bacterium that has become a honeybee pathogen. P. larvae is controlled through antibiotic therapy to non-resistant strains of the pathogen, although there is a thrust to develop alternative treatment strategies including natural antimicrobial compounds such as oils from various plants. Importantly, resistance is rising to oxytetracycline hydrochloride (Terramycin) and new strategies such as the novel antivirulence approach are urgently needed for prevention and control of AFB. Dr. Merrill at the University of Guelph will work with Syngenta Canada to develop effective compounds for treating AFB in honeybees, with a special focus on natural products that serve as therapeutics against the honeybee pathogen. Dr. Merrill's team has developed a rapid and powerful strategy for the discovery and characterization of novel therapeutics against bacterial toxins and they are using this approach to identify new antibacterial compounds
with radically different mechanisms of action which represents an innovative therapeutic concept. To date, the Merrill team has identified a suite of potent inhibitors against the causative agent of AFB, Paenibacillus larvae and its associated virulence factors (toxins) for application in combating this honeybee brood disease. These inhibitors work against the toxins both in vitro and in cell culture. Field studies are needed to test their efficacy